Benzyl Peroxide

PreclinicalSmall molecule

AAlbany Medical College

Benzyl Peroxide is one of 12 small molecule programs targeting Shoulder Arthroplasty. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Shoulder ArthroplastyCompleted

Shoulder ArthroplastyPreclinical

Completed

Competition

Competitive Landscape

11 competitors in Shoulder Arthroplasty

#DrugCompanyPhaseTrials

Tylenol

KKenvue Brands

Approved

3 2

Celebrex

PPhiladelphia Eye Associates

Approved

3 3

Ultram

WWim Janssens

Approved

2 4

Advil

KKenvue Brands

Approved

1 5

Adrenaline

SSamson Clinical Operations Pty Ltd

Approved

1 6

Zanaflex

LLegacy Health System

Approved

1 7

Lyrica

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

1 8

Decadron

AAspen Global Incorporated

Approved

1 9

Toradol

JJavelin Pharmaceuticals

Phase 3

2 10

Magnesium

SSpherium Biomed

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Shoulder Arthroplasty1 trial

The Effect of Pretreatment for Propionibacterium Acnes on Surgical Site Burden in Shoulder Arthroplasty

Completed·—·N/A·NCT04112407·120 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Benzyl Peroxide. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Benzyl Peroxide compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Benzyl Peroxide. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Albany Medical College company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AAlbany Medical College

Benzyl Peroxide

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Shoulder Arthroplasty1 trial

References

Drug Info

Quick Facts

Related News